Voquezna denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for voquezna are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied Voquezna Under Step Therapy

Step therapy (also called "fail first") is UHC's requirement that you try one or more preferred, lower-cost medications — typically proton pump inhibitors (PPIs) — before it will cover a newer branded drug like Voquezna (vonoprazan). If UHC has no record of a prior trial of those preferred agents, it will deny coverage until that step is documented.

## Why This Denial Is Appealable

Step-therapy denials are among the most commonly overturned on appeal, particularly when a prior trial already occurred but was not documented in the PA submission, or when there is a clinical reason the required step agent is inappropriate for this patient.

Federal and state protections: - Step-therapy exception laws: Many states have enacted step-therapy exception statutes requiring insurers to grant an exception when (a) the required drug is contraindicated or clinically inappropriate for the patient, (b) the patient already tried and failed the required drug, or (c) the required drug would cause adverse effects based on the patient's history. Check whether your state's law applies to your plan type. - ACA §2719 external review: After exhausting the internal appeal, an independent external reviewer can override UHC's step-therapy requirement if it is not clinically supported. File within approximately four months of the internal denial notice. - ERISA §503 (employer plans): Requires full disclosure of the criteria used and a genuine clinical review on appeal. - Expedited review: Available when delay would seriously jeopardize your health.

## Documentation to Gather

• UHC's step-therapy policy: Request the written policy listing exactly which agents must be tried and for how long. You are entitled to this document.
• Prior treatment history: A complete, dated medication history showing every PPI or other required agent tried, the duration of each trial, and the clinical outcome (insufficient response, intolerance, adverse effect, or contraindication).
• Prescriber medical-necessity letter: The physician should explain why Voquezna is necessary for this patient, address each required step agent by name (tried and failed, or clinically inappropriate), and cite the patient's diagnosis and severity.
• Objective diagnostic records: Endoscopy reports, pH-impedance studies, or other records documenting the condition and its response — or lack of response — to prior treatment.
• Adverse effect or intolerance documentation: If a step agent caused an adverse reaction, include chart notes documenting it.

## Criteria-Mapping Approach

Obtain UHC's exact step-therapy criteria. For each required prior step:

| UHC required prior step | Your response | |---|---| | Trial of [Step Agent A] | Dates tried, duration, outcome documented in chart | | Adequate duration of trial | Chart notes showing trial length and prescriber's assessment | | Clinical reason to bypass step (if applicable) | Prescriber letter citing contraindication, intolerance, or prior failure |

Address every requirement. If any step was completed but not previously submitted, include that documentation now.

## Next Step

File your internal appeal in writing. Attach the complete prior medication history and the prescriber letter. If denied again, immediately request external review — step-therapy overrides are a recognized and frequently granted basis for external reviewers.